AU2002257497A1 - Derivatives of exendin - Google Patents

Derivatives of exendin

Info

Publication number
AU2002257497A1
AU2002257497A1 AU2002257497A AU2002257497A AU2002257497A1 AU 2002257497 A1 AU2002257497 A1 AU 2002257497A1 AU 2002257497 A AU2002257497 A AU 2002257497A AU 2002257497 A AU2002257497 A AU 2002257497A AU 2002257497 A1 AU2002257497 A1 AU 2002257497A1
Authority
AU
Australia
Prior art keywords
exendin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002257497A
Other versions
AU2002257497B2 (en
Inventor
Chunjuan Shen
Yukun Sun
Dengxi Wu
Gang Yu
Shaoling Zhao
Jiaxiang Zhou
Zhiyong Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Benemae Pharmaceutical Corp
Original Assignee
Shanghai Benemae Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CNB011128569A external-priority patent/CN1162446C/en
Application filed by Shanghai Benemae Pharmaceutical Corp filed Critical Shanghai Benemae Pharmaceutical Corp
Publication of AU2002257497A1 publication Critical patent/AU2002257497A1/en
Application granted granted Critical
Publication of AU2002257497B2 publication Critical patent/AU2002257497B2/en
Assigned to SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION reassignment SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION Request to Amend Deed and Register Assignors: SHANGHAI HUAYI BIO LAB
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU2002257497A 2001-05-10 2002-05-08 Derivatives of exendin Expired AU2002257497B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNB011128569A CN1162446C (en) 2001-05-10 2001-05-10 Insulinotropic hormone secretion peptide derivative
CN01112856.9 2001-05-10
PCT/CN2002/000316 WO2002090388A1 (en) 2001-05-10 2002-05-08 Derivatives of exendin

Publications (2)

Publication Number Publication Date
AU2002257497A1 true AU2002257497A1 (en) 2003-05-01
AU2002257497B2 AU2002257497B2 (en) 2007-10-11

Family

ID=4659603

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002257497A Expired AU2002257497B2 (en) 2001-05-10 2002-05-08 Derivatives of exendin

Country Status (9)

Country Link
US (1) US7329646B2 (en)
EP (2) EP1386930A4 (en)
JP (1) JP4287153B2 (en)
KR (1) KR100902208B1 (en)
CN (1) CN1162446C (en)
AU (1) AU2002257497B2 (en)
BR (1) BRPI0209685B8 (en)
CA (1) CA2446394C (en)
WO (1) WO2002090388A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6924264B1 (en) * 1999-04-30 2005-08-02 Amylin Pharmaceuticals, Inc. Modified exendins and exendin agonists
CN1162446C (en) * 2001-05-10 2004-08-18 上海华谊生物技术有限公司 Insulinotropic hormone secretion peptide derivative
JP2008515856A (en) 2004-10-07 2008-05-15 ノボ ノルディスク アクティーゼルスカブ Delayed GLP-1 compound
JP5107713B2 (en) 2004-10-07 2012-12-26 ノヴォ ノルディスク アー/エス Delayed exendin-4 compound
CN100429227C (en) * 2005-06-29 2008-10-29 常州制药厂有限公司 Exendin 4 polypeptide segment
CN100374462C (en) * 2005-11-21 2008-03-12 大连帝恩生物工程有限公司 Gerobriecin pancrease glucagon peptidel (SGLP-1), its preparation and use
BRPI0712559A2 (en) * 2006-05-26 2012-11-20 Amylin Pharmaceuticals Inc compositions and methods for the treatment of congestive heart failure
CN101125207B (en) * 2006-11-14 2012-09-05 上海华谊生物技术有限公司 Exendin or its analogs with polyethylene group and its preparation and application
EP3456340B1 (en) * 2007-01-08 2022-02-16 The Trustees of the University of Pennsylvania Glp-1 receptor antagonist for use in the treatment of congenital hyperinsulinism
RU2413528C2 (en) 2007-01-18 2011-03-10 Открытое Акционерное Общество "Валента Фармацевтика" Exenatide and dalargin drug for treating diabetes, adminisration and therapy
CN101040936B (en) * 2007-04-28 2011-10-19 大连水产学院 Compound Chinese traditional medicine agent for preventing fish verminosis
CN101215324B (en) * 2007-12-26 2010-11-24 吉林大学 Exenatide short peptide simulation peptide and application thereof in preparing medicament for curing diabetes
KR100864584B1 (en) * 2008-02-25 2008-10-24 성균관대학교산학협력단 Exendin derivative linked biotin, method for the preparation thereof and pharmaceutical composition comprising the same
CN101463078B (en) * 2009-01-12 2011-07-27 华东师范大学 Exendin-4 derivative and solid phase chemical synthesis thereof
CN101665799A (en) * 2009-06-29 2010-03-10 华东师范大学 Recombination preparation method and application of Exendin-4 derivative
WO2011063549A1 (en) * 2009-11-26 2011-06-03 Wu Xiaoyan Long-acting exendin 4 analogues
CN102397558B (en) * 2010-09-09 2013-08-14 中国人民解放军军事医学科学院毒物药物研究所 Positioning pegylation modified compound of Exendin-4 analog and application thereof
CN102532301B (en) * 2010-12-31 2014-09-03 上海医药工业研究院 Novel Exendin-4 analogues and preparation method thereof
CN106928341B (en) * 2011-03-30 2021-06-01 上海仁会生物制药股份有限公司 Fixed-point mono-substituted pegylated Exendin analogue and preparation method thereof
UA116217C2 (en) 2012-10-09 2018-02-26 Санофі Exendin-4 derivatives as dual glp1/glucagon agonists
ES2688367T3 (en) 2012-12-21 2018-11-02 Sanofi Derivatives of exendin-4 as dual agonists of GLP1 / GIP or trigonal of GLP1 / GIP / glucagon
AU2014234314B2 (en) 2013-03-21 2018-02-15 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products
US10087221B2 (en) 2013-03-21 2018-10-02 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
TW201609795A (en) 2013-12-13 2016-03-16 賽諾菲公司 EXENDIN-4 peptide analogues as dual GLP-1/GIP receptor agonists
EP3080152A1 (en) 2013-12-13 2016-10-19 Sanofi Non-acylated exendin-4 peptide analogues
EP3080154B1 (en) 2013-12-13 2018-02-07 Sanofi Dual glp-1/gip receptor agonists
WO2015086733A1 (en) 2013-12-13 2015-06-18 Sanofi Dual glp-1/glucagon receptor agonists
TW201625669A (en) 2014-04-07 2016-07-16 賽諾菲公司 Peptidic dual GLP-1/glucagon receptor agonists derived from Exendin-4
TW201625670A (en) 2014-04-07 2016-07-16 賽諾菲公司 Dual GLP-1/glucagon receptor agonists derived from EXENDIN-4
TW201625668A (en) 2014-04-07 2016-07-16 賽諾菲公司 Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists
US9932381B2 (en) 2014-06-18 2018-04-03 Sanofi Exendin-4 derivatives as selective glucagon receptor agonists
AR105319A1 (en) 2015-06-05 2017-09-27 Sanofi Sa PROPHARMS THAT INCLUDE A DUAL AGONIST GLU-1 / GLUCAGON CONJUGATE HIALURONIC ACID CONNECTOR
TW201706291A (en) 2015-07-10 2017-02-16 賽諾菲公司 New EXENDIN-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69129226T2 (en) 1990-01-24 1998-07-30 Douglas I Buckley GLP-1 ANALOG USES IN DIABETE TREATMENT
US5424286A (en) 1993-05-24 1995-06-13 Eng; John Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
DK144093D0 (en) * 1993-12-23 1993-12-23 Novo Nordisk As
US6265204B1 (en) * 1997-01-17 2001-07-24 Genencor International, Inc. DNA sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi
DK1032587T4 (en) * 1997-11-14 2013-04-08 Amylin Pharmaceuticals Llc New exendin agonist compounds
BR9815670A (en) * 1997-11-14 2000-10-17 Amylin Pharmaceuticals Inc Exendin agonist compounds
US6329336B1 (en) * 1999-05-17 2001-12-11 Conjuchem, Inc. Long lasting insulinotropic peptides
US6514500B1 (en) 1999-10-15 2003-02-04 Conjuchem, Inc. Long lasting synthetic glucagon like peptide {GLP-!}
US6506724B1 (en) 1999-06-01 2003-01-14 Amylin Pharmaceuticals, Inc. Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
EP1076066A1 (en) * 1999-07-12 2001-02-14 Zealand Pharmaceuticals A/S Peptides for lowering blood glucose levels
US6528486B1 (en) 1999-07-12 2003-03-04 Zealand Pharma A/S Peptide agonists of GLP-1 activity
WO2001041561A1 (en) * 1999-12-07 2001-06-14 Lee Yong Hwa A bathtub for a pet dog
CN1162446C (en) * 2001-05-10 2004-08-18 上海华谊生物技术有限公司 Insulinotropic hormone secretion peptide derivative
CN1363654A (en) 2001-07-19 2002-08-14 上海华谊生物技术有限公司 Genetically engineered bacteria and process for preparing insulinotropic hormone secretion peptide GLP-1 (7-36)

Similar Documents

Publication Publication Date Title
AU2002257497A1 (en) Derivatives of exendin
AU2002363005A1 (en) Derivatives of uk-2a
EP1386930A4 (en) Derivatives of exendin
AU2002349676A1 (en) 4-oxoquinoline derivatives
AU2002330453A1 (en) Crystals of hydroxynorephedrine derivative
AU2002347336A1 (en) Quinoline derivatives
AU2002347359A1 (en) Quinoline derivatives
AU2002363600A1 (en) Novel phenyl-propargylether derivatives
AU2002350942A1 (en) Imidazolidineacetic acid derivatives
AU2002338989A1 (en) Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU2002358715A1 (en) Tetrahydrobenzfluorene derivatives
AU2002359458A1 (en) Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases
AU2002359898A1 (en) Preparation of alpha-diimines
AU2002255261A1 (en) Novel use of arylethenessulfonamide derivatives
AU2002255269B8 (en) 2-Iminopyrrolidine derivatives
AU2002307237A1 (en) Carboxybenzopyran derivatives and compositions
AU2002328796A1 (en) Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
AU2002313234A1 (en) Novel endomorphine derivatives
AU2002300773A1 (en) Preparation of Dialkylpyridylboranes
AU2002249205A1 (en) Bis-triazinylaminobenzoxazole derivatives
AU2002253080A1 (en) Biurethane derivatives
AU2002255269A1 (en) 2-Iminopyrrolidine derivatives
AU2002225034A1 (en) Rustmicin derivatives
AU2002350425A1 (en) 6-phenyldihydropyrrolopyrimidinedione derivatives